Progyny, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2021
May 06, 2021 at 02:05 pm EDT
Share
Progyny, Inc. reported unaudited earnings results for the first quarter ended March 31, 2021. For the quarter, the company reported revenue of $122,133,000 against $81,024,000 a year ago. Income from operations was $11,807,000 against $3,431,000 a year ago. Net income was $15,166,000 against $3,629,000 a year ago. Basic net income per share was $0.17 against $0.04 a year ago. Diluted net income per share was $0.15 against $0.04 a year ago.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Companyâs clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a memberâs full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
PROGYNY, INC. 
